Federated Hermes’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.73K Buy
2,097
+468
+29% +$645 ﹤0.01% 1974
2026
Q1
$2.1K Buy
+1,629
New +$2.69K ﹤0.01% 1963
2024
Q1
Sell
-204
Closed -$2.6K 2095
2023
Q4
$2.6K Buy
+204
New +$2.13K ﹤0.01% 1914
2023
Q1
Sell
-140,663
Closed -$1.19M 2202
2022
Q4
$1.19M Buy
+140,663
New +$1.34M ﹤0.01% 1080
2021
Q2
Sell
-30,000
Closed -$1.37M 2276
2021
Q1
$1.37M Hold
30,000
﹤0.01% 1250
2020
Q4
$2.07M Buy
+30,000
New +$1.47M ﹤0.01% 1050

Other funds holding LUNG

Federated Hermes's LUNG Position: Q2 2026 in Review

Federated Hermes increased its Pulmonx (LUNG) stake by 29% in Q2 2026, buying an estimated $645 and bringing the position to 2,097 shares worth $2.73K. The position accounts for ﹤0.01% of the portfolio, ranked #1974.

Federated Hermes first reported a position in LUNG in Q4 2020 and has held it in 6 quarters since. The position peaked at $2.07M in Q4 2020. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Federated Hermes held 2,097 shares of Pulmonx worth $2.73K as of Q2 2026.
  • Federated Hermes bought 468 Pulmonx shares in Q2 2026, an estimated $645.
  • Pulmonx made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1974 holding.
  • Federated Hermes first reported a position in Pulmonx in Q4 2020 and has held it in 6 quarters since.
  • Federated Hermes's Pulmonx position peaked at $2.07M in Q4 2020.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.